Aurora Cannabis (TSE:ACB) had its target price upped by equities research analysts at Canaccord Genuity from C$11.00 to C$13.00 in a research report issued on Wednesday. Canaccord Genuity’s price target suggests a potential upside of 11.30% from the stock’s previous close.
Separately, Eight Capital restated a “buy” rating and set a C$9.00 price target on shares of Aurora Cannabis in a research note on Thursday, August 2nd.
Aurora Cannabis stock opened at C$11.68 on Wednesday. Aurora Cannabis has a 52-week low of C$2.65 and a 52-week high of C$15.20.
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution.
Featured Story: Google Finance Portfolio
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.